Lv6
1680 积分 2025-12-19 加入
Impact of Baseline Kidney Dysfunction on Oral Diuretic Efficacy Following Hospitalization for Heart Failure – Insights from TRANSFORM-HF
18天前
已完结
Comparative Effectiveness and Safety of Torsemide Versus Furosemide in Older Adults With Heart Failure
18天前
已完结
Torsemide vs Furosemide After Discharge and All-Cause Mortality in Patients With Heart Failure
18天前
已完结
Effect of Torsemide vs Furosemide After Discharge on All-Cause Mortality in Patients Hospitalized With Heart Failure
18天前
已完结
Efficacy and safety of oral Pcsk9 inhibitors: insights from a meta-analysis of RCTs
28天前
已完结
1246-OR: Efficacy and Safety of Enlicitide, an Oral PCSK9 Inhibitor, in Participants with and without Diabetes Mellitus in a Pooled Analysis of Two Phase 3 Trials
28天前
已完结
Oral PCSK9 Inhibitor Enlicitide versus Oral Non-statin Therapies: A Phase 3 Randomized Clinical Trial
28天前
已完结
Efficacy and Safety of Oral PCSK9 Inhibitor Enlicitide in Adults With Heterozygous Familial Hypercholesterolemia
28天前
已完结
A Placebo-Controlled Trial of the Oral PCSK9 Inhibitor Enlicitide
28天前
已完结
Low-dose rivaroxaban associated with lower incidence of all-cause mortality and bleeding complications in older patients with non-valvular atrial fibrillation
1个月前
已关闭
皖公网安备34019202002308
